Tau haplotypes regulate transcription and are associated with Parkinson's disease

被引:136
作者
Kwok, JBJ
Teber, ET
Loy, C
Hallupp, M
Nicholson, G
Mellick, GD
Buchanan, DD
Silburn, PA
Schofield, PR
机构
[1] Garvan Inst Med Res, Sydney, NSW 2010, Australia
[2] Univ New S Wales, Sydney, NSW, Australia
[3] Anzac Res Inst, Sydney, NSW, Australia
[4] Univ Queensland, Dept Med, Brisbane, Qld, Australia
关键词
D O I
10.1002/ana.10826
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A primary haplotype (H1) of the microtubule-associated protein Tau (MAPT) gene is associated with Parkinson's disease (PD). However, the mechanism for disease susceptibility remains unknown. We examined the promoter region of MAPT and identified single nucleotide polymorphisms and insertions of 1 to 11 nucleotides. These polymorphisms corresponded to the previously characterized haplotypes, H1 and H2, as well as a novel variant of the H1 haplotype, H1'. As observed in other studies, we demonstrated a significant association with the H1/H1 promoter genotype and PD in a cohort of 206 idiopathic late-onset cases. This is in contrast with a panel of 13 early-onset PD patients, for whom we did not detect any mutations in MAPT. By examining single nucleotide polymorphisms in adjacent genes, we showed that linkage disequilibrium does not extend beyond the MAPT haplotype to neighboring genes. To define the mechanism of disease susceptibility, we examined the transcriptional activity of the promoter haplotypes using a luciferase reporter assay. We demonstrated in two human cell lines, SK-N-MC and 293, that the H1 haplotype was more efficient at driving gene expression than the H2 haplotype. Our data suggest that an increase in expression of the MAPT gene is a susceptibility factor in idiopathic PD.
引用
收藏
页码:329 / 334
页数:6
相关论文
共 33 条
[1]   Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies [J].
Arima, K ;
Hirai, S ;
Sunohara, N ;
Aoto, K ;
Izumiyama, Y ;
Uéda, K ;
Ikeda, K ;
Kawai, M .
BRAIN RESEARCH, 1999, 843 (1-2) :53-61
[2]  
Baba M, 1998, AM J PATHOL, V152, P879
[3]   Association of an extended haplotype in the tau gene with progressive supranuclear palsy [J].
Baker, M ;
Litvan, I ;
Houlden, H ;
Adamson, J ;
Dickson, D ;
Perez-Tur, J ;
Hardy, J ;
Lynch, T ;
Bigio, E ;
Hutton, M .
HUMAN MOLECULAR GENETICS, 1999, 8 (04) :711-715
[4]   The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients [J].
Buchanan, DD ;
Silburn, PA ;
Chalk, JB ;
Le Couteur, DG ;
Mellick, GD .
NEUROSCIENCE LETTERS, 2002, 327 (02) :91-94
[5]   CRITERIA FOR DIAGNOSING PARKINSONS-DISEASE [J].
CALNE, DB ;
SNOW, BJ ;
LEE, C .
ANNALS OF NEUROLOGY, 1992, 32 :S125-S127
[6]   The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease [J].
de Silva, R ;
Hardy, J ;
Crook, J ;
Khan, N ;
Graham, EA ;
Morris, CM ;
Wood, NW ;
Lees, AJ .
NEUROSCIENCE LETTERS, 2002, 330 (02) :201-203
[7]   Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy [J].
de Silva, R ;
Weiler, M ;
Morris, HR ;
Martin, ER ;
Wood, NW ;
Lees, AJ .
NEUROSCIENCE LETTERS, 2001, 311 (03) :145-148
[8]  
Di Maria E, 2000, ANN NEUROL, V47, P374, DOI 10.1002/1531-8249(200003)47:3<374::AID-ANA15>3.3.CO
[9]  
2-#
[10]   Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans [J].
Ezquerra, M ;
Pastor, P ;
Valldeoriola, F ;
Molinuevo, JL ;
Blesa, R ;
Tolosa, E ;
Oliva, R .
NEUROSCIENCE LETTERS, 1999, 275 (03) :183-186